Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call
DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…
Pharmaceuticals, Biotechnology and Life Sciences
DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…
GAINESVILLE, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) — NeXtGen Biologics announced today the successful completion of a two-day inspection by…
Aggregated presentation by day and by marketStatement of transactions in own shares from October 20th to October 24th 2025 Name of…
Crafted with Clean Green Certified™ flower and award-winning Live Resin SauceSANTA BARBARA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Raw…
ALBANY, N.Y., Oct. 28, 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization,…
KEY LARGO, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) — Remedy’s Nutrition®, a trusted natural dietary supplement company since 1972 and…
LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) — Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for…
BURLINGTON, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (Nasdaq: NEUP), a clinical-stage biotechnology…
SALT LAKE CITY, Oct. 27, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing…
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) — Immunovant (Nasdaq: IMVT) today announced that it will report its financial results…